Maternal and infant characteristics associated with maternal opioid overdose in the year following delivery
- PMID: 31692133
- PMCID: PMC7066531
- DOI: 10.1111/add.14825
Maternal and infant characteristics associated with maternal opioid overdose in the year following delivery
Abstract
Background and aims: Opioid-related overdose is increasingly linked to pregnancy-associated deaths, but factors associated with postpartum overdose are unknown. We aimed to estimate the strength of the association between maternal and infant characteristics and postpartum opioid-related overdose.
Design: Retrospective cohort study using a linked, population-level data set.
Setting: Massachusetts, United States.
Conclusion: Among women who delivered live infants in Massachusetts, USA between 2012 and 2014, maternal diagnosis of OUD, prior non-fatal overdose, infant diagnosis of NAS and high unscheduled health-care utilization appeared to be positively associated with postpartum opioid overdose. However, more than half of postpartum overdoses in that period were to women without a diagnosis of OUD. Engagement in methadone or buprenorphine treatment in the month prior to delivery was not sufficient to reduce the odds of postpartum overdose.
Participants: Women who delivered one or more live births from 2012 to 2014 (n = 174 517).
Measurements: The primary outcome was opioid-related overdose in the postpartum year. We used multivariable logistic regression to explore the independent associations of maternal (demographics, substance use, pregnancy) and infant [gestational age, birthweight, neonatal abstinence syndrome (NAS)] characteristics with postpartum opioid overdose. Findings were stratified by maternal opioid use disorder (OUD) diagnosis.
Findings: There were 189 deliveries to women who experienced ≥ 1 opioid overdose in the first year postpartum (11 of 10 000 deliveries). Among women with postpartum opioid overdose, 46.6% had an OUD diagnosis within 12 months before delivery. In our adjusted model, maternal diagnosis of OUD [adjusted odds ratio (aOR) = 3.61, 95% confidence interval (CI) = 1.73-7.51] and prior non-fatal overdose (aOR = 2.40, 95% CI = 1.11-5.17) were most strongly associated with postpartum overdose. After stratifying by OUD status, infant diagnosis of NAS (OUD+ aOR = 2.03, 95% CI = 1.26-3.27; OUD- aOR = 2.79, 95% CI = 1.12-6.93) and high unscheduled health-care utilization (OUD+ aOR = 2.27, 95% CI = 1.38-3.73; OUD- aOR = 2.11, 95% CI = 1.24-3.58) were positively associated with postpartum overdose in both groups.
Keywords: Maternal; neonatal abstinence syndrome; non-fatal; opioid use disorder; overdose; postpartum; pregnancy; women.
© 2019 Society for the Study of Addiction.
Conflict of interest statement
Figures
Comment in
-
Rooming-in and loss of child custody: key factors in maternal overdose risk.Addiction. 2020 Sep;115(9):1786-1787. doi: 10.1111/add.15028. Epub 2020 Apr 27. Addiction. 2020. PMID: 32141135 Free PMC article. No abstract available.
-
IMPROVING MEASURES OF DYADIC OUTCOMES IN PERINATAL SUBSTANCE USE RESEARCH.Addiction. 2020 Sep;115(9):1787-1788. doi: 10.1111/add.15041. Epub 2020 Mar 24. Addiction. 2020. PMID: 32143238 No abstract available.
References
-
- Kavanaugh V Pregnancy-Associated Deaths From Drug Overdose in Virginia, 1999–2007: A Report from the Virginia Maternal Mortality Review Team; 2015.
-
- Massachusetts Department of Public Health. Substance Use among Pregnancy-Associated Deaths — 2005–2014. In: Maternal Mortality and Morbidity Review in Massachusetts: 2018.